Literature DB >> 9600455

Germline mutations in Peruvian patients with hemophilia B: pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern.

J A Heit1, E C Thorland, R P Ketterling, T J Lind, T M Daniels, R E Zapata, S M Ordonez, C K Kasper, S S Sommer.   

Abstract

Exogenous (e.g., environmental) mutagens produce characteristic patterns of mutation. In contrast, endogenous mutation processes likely are associated with an invariant pattern of mutation. Analysis of factor IX gene mutations among large samples of hemophilia B patients from multiple, widely divergent geographic and ethnic populations reveals a remarkably constant mutational pattern, suggesting that the primary germline mutational process results from endogenous processes rather than environmental mutagens. To test this hypothesis further, we have initiated a study of hemophilia B patients from Peru because relatively large populations of AmerIndians can be found with low admixtures of other races. To determine if the factor IX (FIX) germline mutational pattern in AmerIndians differs from the common and putative endogenous pattern, FIX gene mutations were characterized in an initial sample of 10 AmerIndian Peruvian patients with hemophilia B. A minimum of 2.2 kb of the FIX gene was examined by PCR and direct sequencing of all eight exons, the splice junctions, and the promoter region. The pattern of germline mutation in AmerIndians was similar to the pattern of FIX germline mutations from larger U. S. Caucasian or Mexican Hispanic samples (P=0.55 and 0.63, respectively). The similar pattern in this initial sample of the Peru AmerIndian population provides additional support for the inference that the FIX germline mutational pattern results from predominantly endogenous processes rather than exogenous mutagens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600455     DOI: 10.1002/(SICI)1098-1004(1998)11:5<372::AID-HUMU4>3.0.CO;2-M

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

1.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

2.  Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity.

Authors:  Alessio Branchini; Matteo Campioni; Maria Gabriella Mazzucconi; Francesca Biondo; Rosella Mari; Maria Patrizia Bicocchi; Francesco Bernardi; Mirko Pinotti
Journal:  FEBS Lett       Date:  2013-08-27       Impact factor: 4.124

3.  The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis.

Authors:  Tomomi Ishikawa; Hisataka Kitano; Atsushi Mamiya; Shinichiro Kokubun; Chiaki Hidai
Journal:  Biosci Rep       Date:  2016-06-03       Impact factor: 3.840

4.  CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs.

Authors:  Jiahuan Chen; Beiying An; Biao Yu; Xiaohuan Peng; Hongming Yuan; Qiangbing Yang; Xue Chen; Tingting Yu; Lingyu Wang; Xinwei Zhang; He Wang; Xiaodong Zou; Daxin Pang; Hongsheng Ouyang; Xiaochun Tang
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.